HRTX
Heron Therapeutics (HRTX)
$76
About Heron Therapeutics (HRTX)
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.
Details
Daily high
$0.82
Daily low
$0.75
Price at open
$0.80
52 Week High
$2.61
52 Week Low
$0.75
Market cap
150.8M
Dividend yield
0.00%
Volume
1.5M
Avg. volume
2.4M
P/E ratio
-6.64
Heron Therapeutics News
Details
Daily high
$0.82
Daily low
$0.75
Price at open
$0.80
52 Week High
$2.61
52 Week Low
$0.75
Market cap
150.8M
Dividend yield
0.00%
Volume
1.5M
Avg. volume
2.4M
P/E ratio
-6.64